Glenmark Pharmaceuticals S.a.

Glenmark Life Sciences Limited

Sandeep Bandu Khandagale

Suresh Mahadev Kadam

Sachin Baban Gavhane

Laxmikant Atmaram Gharat

Nagarajan Muthukaman

Sunil P Nirgude

Rajesh Kumar Dwivedi

Abraham Thomas

Shekhar Bhaskar Bhirud

Sukeerthi Kumar

Sukumar Sinha

Bipin Parsottam Kansagra

Jayant Prakashrao Patil

Shailendra Nilkanth Bhadane

Shailesh Shrirang Pawase

Sunil Pandurang Nirgude

Ajit Shankar Mindhe

Bhavna Mishra

Shailesh Pawase

Shailendra Bhadane

Rajesh Dwivedi

Sachin Gavhane

The present invention relates to a process for preparation of apremilast. The present invention relates to p-xylene solvate of apremilast and process for its preparation.

Process for the preparation of apremilast

The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl)pivalamide (Compound of formula II), and process for preparation thereof. 

Polymorphs of a mPGES-1 inhibiting triazolone compound

The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl) pivalamide (Compound of formula II), and process for preparation thereof. 

The present disclosure is directed to salts of N-{4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl}dimethyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-5-yl)acetamide and process for the preparation thereof (formula II). 

Amides of 2-amino-4-arylthiazole compounds and their salts

Growing community of inventors

Thane, India

Sandeep Bandu Khandagale